Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma

Oncology Reports

Volumn 31, Issue 3, 2014, Pages 1157-1164

  Zhang, Jing ^a   Zhao, Chen Yan ^a   Zhang, Shu Hui ^b   Yu, Dang Hui ^a   Chen, Ying ^a   Liu, Qing Hua ^a   Shi, Min ^a   Ni, Can Rong ^a   Zhu, Ming Hua ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Diagnosis; Growth; MicroRNA; Pancreatic ductal adenocarcinoma; Progression; Targets

Indexed keywords

MICRORNA; MICRORNA 139; MICRORNA 192; MICRORNA 194; MICRORNA 212; MICRORNA 30C; MICRORNA 34A; MICRORNA 508; MICRORNA 513A; MICRORNA 516A; MICRORNA 602; MICRORNA 630; MICRORNA 801; MICRORNA 887; MICRORNA 923; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER GROWTH; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; DUODENUM CARCINOMA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; TUMOR SUPPRESSOR GENE; TUMOR SUPPRESSOR GENE DACH1; UPREGULATION;

ADULT; AGED; ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; ROC CURVE; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84896737787     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2960     Document Type: Article

References (31)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Li D, Xie K, Wolff R and Abbruzzese JL: Pancreatic cancer. Lancet 363: 1049-1057, 2004. (Pubitemid 38410779)
3. Brand RE and Matamoros A: Imaging techniques in the evaluation of adenocarcinoma of the pancreas. Dig Dis 16: 242-252, 1998. (Pubitemid 128531138)
4. Yates LA, Norbury CJ and Gilbert RJ: The long and short of microRNA. Cell 153: 516-519, 2013.
5. Fabbri M: MicroRNAs and cancer: towards a personalized medicine. Curr Mol Med 13: 751-756, 2013.
6. Ahmed FE: Role of miRNA in carcinogenesis and biomarker selection: a methodological view. Expert Rev Mol Diagn 7: 569-603, 2007.
7. Cowland JB, Hother C and Grønbaek K: MicroRNAs and cancer. APMIS 115: 1090-1106, 2007. (Pubitemid 350179476)
8. Madhavan D, Cuk K, Burwinkel B and Yang R: Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures. Front Genet 4: 116, 2013.
9. Liffers ST, Munding JB, Vogt M, et al: MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Lab Invest 91: 1472-1479, 2011.
10. Bhatti I, Lee A, James V, et al: Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. J Gastrointest Surg 15: 199-208, 2011.
11. Liu R, Chen X, Du Y, et al: Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 58: 610-618, 2012.
12. Munding JB, Adai AT, Maghnouj A, et al: Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Int J Cancer 131: E86-E95, 2012.
13. Ekström K, Bossios A, Sjöstrand M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659, 2007.
14. Zhao C, Zhang J, Zhang S, et al: Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. Oncol Rep 30: 276-284, 2013.
15. Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD and Kloecker GH: Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 10: 42-46, 2009.
16. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
17. Xue Y, Abou Tayoun AN, Abo KM, et al: MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. Cancer Genet 206: 217-221, 2013.
18. Kawaguchi T, Komatsu S, Ichikawa D, et al: Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer. Br J Cancer 108: 361-369, 2013.
19. Giovannetti E, van der Velde A, Funel N, et al: High-throughput microRNA (miRNAs) arrays unravel the prognostic role of miR-211 in pancreatic cancer. PLoS One 7: e49145, 2012.
20. Mees ST, Mardin WA, Wendel C, et al: EP300 - a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. Int J Cancer 126: 114-124, 2010.
21. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y and Ochiya T: Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285: 17442-17452, 2010.
22. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
23. Redova M, Poprach A, Nekvindova J, et al: Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med 10: 55, 2012.
24. Wang J, Chen J, Chang P, et al: MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res 2: 807-813, 2009.
25. Khella HW, Bakhet M, Allo G, et al: miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma. Carcinogenesis 34: 2231-2239, 2013.
26. Meng Z, Fu X, Chen X, et al: miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology 52: 2148-2157, 2010.
27. Iizuka D, Imaoka T, Nishimura M, Kawai H, Suzuki F and Shimada Y: Aberrant microRNA expression in radiation-induced rat mammary cancer: the potential role of miR-194 overexpression in cancer cell proliferation. Radiat Res 179: 151-159, 2013.
28. Sundaram P, Hultine S, Smith LM, et al: p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers. Cancer Res 71: 7490-7501, 2011.
29. Popov VM, Zhou J, Shirley LA, et al: The cell fate determination factor DACH1 is expressed in estrogen receptor-α-positive breast cancer and represses estrogen receptor-α signaling. Cancer Res 69: 5752-5760, 2009.
30. Watanabe A, Ogiwara H, Ehata S, et al: Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cells. Proc Natl Acad Sci USA 108: 12384-12389, 2011.
31. Wu K, Katiyar S, Witkiewicz A, et al: The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth. Cancer Res 69: 3347-3355, 2009.